An agent that inhibits colony growth when added and allows the colony to regrow when removed is called:
All are true about ESBL except -
Transfer of drug resistance in *Staphylococcus* is by:
The following phenomenon is responsible for antibiotic resistance in bacteria due to slime production -
The molecular basis of penicillin resistance in *S. pneumoniae* is:
Drug resistance is not transmitted by-
All of the following are true about methicillin resistance in MRSA, except:
Which of the following is true about Extended spectrum beta-lactamases?
The most common genetic element responsible for drug resistance in staphylococci is:
Antibiotic sensitivity and resistance of microorganisms are determined by
Explanation: ***Bacteriostatic*** - **Bacteriostatic** agents inhibit bacterial growth without killing the bacteria, allowing **regrowth** once the agent is removed. - This mechanism relies on the host's immune system to clear the inhibited pathogens. *Antibiotic* - This is a broad category of agents that can be either **bactericidal** (killing bacteria) or **bacteriostatic** (inhibiting growth). - It doesn't specifically describe the reversible nature of inhibition mentioned in the question. *Antiseptic* - **Antiseptics** are antimicrobial substances applied to living tissue or skin to reduce the possibility of infection or sepsis. - They are typically used topically and often have a **bactericidal** effect. *Bactericidal* - **Bactericidal** agents kill bacteria directly, leading to permanent cessation of colony growth. - If a bactericidal agent were removed, the killed bacteria would not regrow.
Explanation: ***Resistant to carbapenems*** - **ESBL (Extended-Spectrum Beta-Lactamase)**-producing bacteria are typically **susceptible to carbapenems**. Carbapenems are a primary treatment option for serious ESBL infections. - Resistance to carbapenems suggests the presence of other resistance mechanisms, such as **carbapenemases**, not ESBLs. *Classification is based on 3rd generation cephalosporin sensitivity* - ESBLs are specifically defined by their ability to hydrolyze and confer resistance to **extended-spectrum cephalosporins** (e.g., ceftriaxone, ceftazidime) and aztreonam. - This characteristic resistance to third-generation cephalosporins is key to their definition and clinical identification. *Cephalosporin sensitivity testing is required to confirm ESBL* - **Phenotypic confirmatory tests** for ESBLs involve demonstrating increased resistance to an extended-spectrum cephalosporin alone compared to the same cephalosporin combined with a **beta-lactamase inhibitor** like clavulanic acid. - This testing is crucial for accurate detection and guiding appropriate antibiotic therapy. *Ambler classification is based on molecular structure* - The **Ambler classification system** categorizes beta-lactamases into classes A, B, C, and D based on their **amino acid sequence homology** and their active site mechanisms. - This classification helps in understanding the biochemical properties and substrate profiles of different beta-lactamases, including ESBLs.
Explanation: ***Transduction*** - **Transduction** is a common mechanism for the transfer of antibiotic resistance genes in *Staphylococcus aureus*, particularly for methicillin resistance (*mecA* gene). - This process involves **bacteriophages (viruses)** infecting bacterial cells and transferring genetic material, including resistance genes, from one bacterium to another. *Conjugation* - **Conjugation** involves direct cell-to-cell contact between bacteria, typically through a **pilus**, to transfer plasmids containing resistance genes. - While conjugation can occur in staphylococci, it is less common for widespread drug resistance dissemination than transduction, especially for *mecA*. *Transfection* - **Transfection** is the process of introducing **foreign nucleic acids (DNA or RNA)** into eukaryotic cells, often used in molecular biology research. - This term is not typically used to describe natural gene transfer mechanisms between bacteria. *Transformation* - **Transformation** involves the uptake of **naked DNA** from the environment by a bacterial cell. - While *Staphylococcus aureus* can undergo transformation, it is generally less efficient and frequent than transduction for the acquisition of significant resistance traits, especially in clinical settings.
Explanation: ***Biofilm formation*** - **Slime production** by bacteria is a key component of **biofilm formation**, creating a protective matrix around bacterial colonies. - This **biofilm acts as a physical barrier**, reducing the penetration of antibiotics and host immune cells, thereby contributing significantly to **antibiotic resistance**. *Mutation evolving a target by pass mechanism* - This refers to a genetic change where bacteria develop a **new metabolic pathway** or enzyme to bypass the inhibited target of an antibiotic. - While it causes antibiotic resistance, it is a **genetic alteration** and not directly linked to **slime production** or the physical protection offered by a biofilm. *Co-aggregation* - **Co-aggregation** describes the specific interaction and adherence between different species of bacteria. - While important for the **development of complex microbial communities**, it is a phenomenon of bacterial interaction, not the primary mechanism by which **slime production** leads to antibiotic resistance. *Mutation evolving in altered target site for antibiotics* - This describes a genetic mutation that modifies the specific **molecular target** (e.g., ribosome, cell wall enzyme) that an antibiotic usually binds to. - This alteration reduces the antibiotic's binding affinity and effectiveness, but it is a **molecular mechanism of resistance** distinct from the physical barrier provided by **slime production** in biofilms.
Explanation: ***Alteration of penicillin-binding protein*** - The primary mechanism of **penicillin resistance in *Streptococcus pneumoniae*** involves modifications to its **penicillin-binding proteins (PBPs)**, which are the targets of penicillin. - These alterations reduce the affinity of PBPs for penicillin, allowing cell wall synthesis to continue even in the presence of the antibiotic. *Alteration in cell membranes* - Changes in cell membranes are not the primary mechanism of **penicillin resistance** in bacteria. - **Penicillins** primarily target the **bacterial cell wall**, not the cell membrane. *Alteration in the cell wall* - While penicillin resistance *involves* the cell wall, the direct "alteration in the cell wall" itself is not the molecular basis. - The key is the change in the **PBPs** located within or associated with the cell wall, not a general change in the cell wall structure. *Production of beta-lactamase enzyme* - **Beta-lactamase production** is a common mechanism of penicillin resistance in many bacteria (e.g., *Staphylococcus aureus*, *Haemophilus influenzae*), but it is **not the primary mechanism for penicillin resistance in *Streptococcus pneumoniae***. - *S. pneumoniae* primarily relies on **altered PBPs** to evade penicillin, rather than enzymatic degradation of the antibiotic.
Explanation: ***Ribosomes*** - Ribosomes are responsible for **protein synthesis** and do not carry or transmit genetic information for **drug resistance**. - While ribosomal mutations can sometimes lead to drug resistance, the ribosome itself is not a vehicle for its transmission between bacteria. *Plasmids* - **Plasmids** are small, extrachromosomal DNA molecules that can replicate independently and are a primary means of **horizontal gene transfer** for drug resistance genes. - They can be easily transferred between bacteria through **conjugation**, rapidly spreading resistance. *Chromosomes* - **Drug resistance genes** can be located on the bacterial chromosome and are passed down to daughter cells during **vertical gene transfer** (cell division). - While less frequent for initial acquisition compared to plasmids, chromosomal mutations and integrated resistance genes are significant causes of **antibiotic resistance**. *Transposons* - **Transposons**, or jumping genes, are DNA sequences that can move from one location in the genome to another, including between **plasmids and chromosomes**. - They often carry **antibiotic resistance genes** and facilitate their spread within a bacterial genome or between different genetic elements.
Explanation: ***Resistance is primarily mediated/transmitted by plasmids*** - Methicillin resistance in MRSA is primarily mediated by the acquisition of the **mecA gene**, which encodes for an altered **penicillin-binding protein (PBP2a)**. - The mecA gene is located on a **staphylococcal chromosomal cassette mec (SCCmec)**, a mobile genetic element integrated into the bacterial chromosome, and **not transmitted via plasmids**. - This is the **false statement** and hence the correct answer to this "except" question. *Resistance is produced as a result of altered PBPs* - This statement is **true** as MRSA acquires the **mecA gene**, which encodes for an altered penicillin-binding protein, **PBP2a**. - **PBP2a** has a low affinity for beta-lactam antibiotics, allowing the bacterium to synthesize its cell wall even in the presence of these drugs. *Resistance may be missed at incubation temperature of 37°C during susceptibility testing* - This statement is **true**; **MRSA expression** can be heterogeneous and temperature-dependent. - Optimal detection of methicillin resistance often requires incubation at **lower temperatures (e.g., 30-35°C)** and/or the addition of salt (2-4% NaCl), as 37°C can sometimes mask the heterogeneous expression of resistance. *Resistance is associated with increased minimum inhibitory concentrations (MICs) for beta-lactam antibiotics* - This statement is **true**; the presence of **PBP2a** results in reduced binding of beta-lactam antibiotics to their target. - This leads to **increased MICs** for methicillin and other beta-lactam antibiotics, defining the resistance phenotype.
Explanation: ***Plasmid mediated*** - **Extended-spectrum beta-lactamases (ESBLs)** are primarily encoded on **plasmids**, which allows for easy horizontal transfer of resistance genes between bacteria. - This **plasmid-mediated dissemination** is a major reason for the rapid spread of ESBL resistance among various bacterial species. *Only seen in gram positive bacteria* - ESBLs are predominantly found in **Gram-negative bacteria**, particularly members of the **Enterobacteriaceae family** like *E. coli* and *Klebsiella pneumoniae*. - While some beta-lactamases exist in Gram-positive bacteria, ESBLs specifically refer to those with an extended spectrum of activity against modern beta-lactams in Gram-negative organisms. *Only seen in gram negative bacteria* - While **ESBLs are predominantly found in Gram-negative bacteria**, the phrasing "only seen in gram negative bacteria" is too restrictive because there have been rare reports of ESBL genes detected in some Gram-positive strains, though this is not their primary epidemiology. - The main concern with ESBLs lies in their prevalence and impact on Gram-negative infections. *Associated only in community acquired disease* - ESBLs are associated with both **hospital-acquired (nosocomial)** and **community-acquired infections**. - The prevalence of community-acquired ESBL infections has been increasing, posing a significant public health challenge.
Explanation: ***Plasmids*** - **Plasmids** are extrachromosomal DNA molecules that carry genes for antibiotic resistance, including **β-lactamase genes** and the **mecA gene** (responsible for methicillin resistance in MRSA). - Plasmids are the **primary genetic vehicles** for resistance in staphylococci and can be transferred between bacteria through various mechanisms (transduction, conjugation, transformation). - They enable rapid dissemination of **multi-drug resistance** patterns in staphylococcal populations. *Transduction* - **Transduction** is a horizontal gene transfer **mechanism** via bacteriophages, not a genetic element itself. - While transduction is actually the **most common transfer mechanism** in staphylococci (especially for plasmid and chromosomal DNA transfer), it is the **process** of transfer, not the genetic element carrying resistance genes. - The question asks about the genetic element, not the transfer mechanism. *Conjugation* - **Conjugation** is another horizontal gene transfer **mechanism** involving direct cell-to-cell contact, not a genetic element. - Conjugation is **relatively rare** in staphylococci compared to Gram-negative bacteria, though it can occur with certain plasmids. - Like transduction, this is a transfer process, not the genetic vehicle itself. *Translation* - **Translation** is the cellular process of protein synthesis from mRNA by ribosomes, completely unrelated to resistance gene acquisition. - While translation produces resistance proteins (like β-lactamase enzymes), it does not represent the genetic element that carries or transfers resistance genes.
Explanation: ***Culture*** - **Culture** allows for the isolation and growth of microorganisms, which is essential for subsequent testing of their susceptibility to various antibiotics. - Standardized methods like the **Kirby-Bauer disk diffusion method** or **broth microdilution** are performed on cultured organisms to determine antibiotic sensitivity and resistance. *DNA probe* - **DNA probes** are primarily used for identifying specific genes or sequences within a microorganism, often for rapid identification or detection of resistance genes, but not for direct determination of phenotypic susceptibility. - While they can detect genetic markers associated with resistance, they don't directly measure how an antibiotic affects the *growth* of the organism. *Direct microscopy* - **Direct microscopy** is used to visualize microorganisms, determine their morphology, and estimate their quantity in a sample. - It does not provide information about a microorganism's ability to grow in the presence of antibiotics. *ELISA* - **ELISA (Enzyme-Linked Immunosorbent Assay)** is an immunological test used to detect antigens or antibodies in a sample. - It is used for diagnosis of infections or detection of toxins, but not for determining the susceptibility of microorganisms to antibiotics.
Mechanisms of Antimicrobial Resistance
Practice Questions
Beta-lactamase Producing Organisms
Practice Questions
Methicillin-Resistant Staphylococcus aureus
Practice Questions
Vancomycin-Resistant Enterococci
Practice Questions
Carbapenem-Resistant Enterobacteriaceae
Practice Questions
Multi-drug Resistant Tuberculosis
Practice Questions
Antimicrobial Stewardship
Practice Questions
Detection of Antimicrobial Resistance
Practice Questions
Global Surveillance of Resistance
Practice Questions
New Antimicrobial Development
Practice Questions
Alternative Approaches to Antimicrobial Therapy
Practice Questions
One Health Approach to Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free